Zomedica Pharmaceuticals Corp Stock Price History
| ZOM Stock | USD 0.13 0.01 8.33% |
Below is the normalized historical share price chart for Zomedica Pharmaceuticals Corp extending back to July 29, 2016. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Zomedica Pharmaceuticals stands at 0.13, as last reported on the 23rd of April, with the highest price reaching 0.13 and the lowest price hitting 0.12 during the day.
If you're considering investing in Zomedica Stock, it is important to understand the factors that can impact its price. We consider Zomedica Pharmaceuticals dangerous. Zomedica Pharmaceuticals shows Sharpe Ratio of 0.0284, which attests that the company had a 0.0284% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Zomedica Pharmaceuticals, which you can use to evaluate the volatility of the company. Please check out Zomedica Pharmaceuticals' Market Risk Adjusted Performance of 0.1207, mean deviation of 3.48, and Downside Deviation of 8.85 to validate if the risk estimate we provide is consistent with the expected return of 0.17%.
At this time, Zomedica Pharmaceuticals' Total Stockholder Equity is very stable compared to the past year. As of the 23rd of April 2024, Liabilities And Stockholders Equity is likely to grow to about 265.9 M, while Capital Stock is likely to drop about 243.6 M. . As of the 23rd of April 2024, Price To Sales Ratio is likely to drop to 7.40. In addition to that, Price Earnings Ratio is likely to drop to -5.97. Zomedica Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 29th of July 2016 | 200 Day MA 0.1671 | 50 Day MA 0.135 | Beta 0.982 |
Zomedica |
Sharpe Ratio = 0.0284
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ZOM | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 5.81 actual daily | 51 51% of assets are less volatile |
Expected Return
| 0.17 actual daily | 3 97% of assets have higher returns |
Risk-Adjusted Return
| 0.03 actual daily | 2 98% of assets perform better |
Based on monthly moving average Zomedica Pharmaceuticals is performing at about 2% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Zomedica Pharmaceuticals by adding it to a well-diversified portfolio.
Price Book 0.5512 | Enterprise Value Ebitda (1.52) | Price Sales 5.2527 | Shares Float 963.3 M | Wall Street Target Price 0.44 |
Zomedica Pharmaceuticals Stock Price History Chart
There are several ways to analyze Zomedica Stock price data. The simplest method is using a basic Zomedica candlestick price chart, which shows Zomedica Pharmaceuticals price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | March 1, 2024 | 0.16 |
| Lowest Price | February 16, 2024 | 0.12 |
Zomedica Pharmaceuticals April 23, 2024 Stock Price Synopsis
Various analyses of Zomedica Pharmaceuticals' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Zomedica Stock. It can be used to describe the percentage change in the price of Zomedica Pharmaceuticals from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Zomedica Stock.| Zomedica Pharmaceuticals Price Action Indicator | 0.01 | |
| Zomedica Pharmaceuticals Price Daily Balance Of Power | 1.00 | |
| Zomedica Pharmaceuticals Price Rate Of Daily Change | 1.08 |
Zomedica Pharmaceuticals April 23, 2024 Stock Price Analysis
Zomedica Stock Price History Data
The price series of Zomedica Pharmaceuticals for the period between Wed, Jan 24, 2024 and Tue, Apr 23, 2024 has a statistical range of 0.04 with a coefficient of variation of 5.55. The daily prices for the period are distributed with arithmetic mean of 0.13. The median price for the last 90 days is 0.13.| Open | High | Low | Close | Volume | ||
04/23/2024 | 0.12 | 0.13 | 0.12 | 0.13 | ||
| 04/22/2024 | 0.12 | 0.13 | 0.12 | 0.13 | 3,843,600 | |
| 04/19/2024 | 0.13 | 0.13 | 0.12 | 0.12 | 6,583,800 | |
| 04/18/2024 | 0.13 | 0.13 | 0.13 | 0.13 | 2,625,248 | |
| 04/17/2024 | 0.13 | 0.13 | 0.13 | 0.13 | 1,667,500 | |
| 04/16/2024 | 0.13 | 0.13 | 0.13 | 0.13 | 3,749,070 | |
| 04/15/2024 | 0.14 | 0.14 | 0.13 | 0.14 | 4,096,531 | |
| 04/12/2024 | 0.14 | 0.14 | 0.14 | 0.14 | 3,123,500 | |
| 04/11/2024 | 0.14 | 0.14 | 0.14 | 0.14 | 2,530,500 | |
| 04/10/2024 | 0.14 | 0.14 | 0.14 | 0.14 | 1,732,014 | |
| 04/09/2024 | 0.14 | 0.14 | 0.14 | 0.14 | 2,915,200 | |
| 04/08/2024 | 0.14 | 0.15 | 0.14 | 0.14 | 4,182,548 | |
| 04/05/2024 | 0.14 | 0.14 | 0.14 | 0.14 | 3,265,235 | |
| 04/04/2024 | 0.15 | 0.15 | 0.14 | 0.14 | 5,297,348 | |
| 04/03/2024 | 0.14 | 0.14 | 0.14 | 0.14 | 3,552,800 | |
| 04/02/2024 | 0.14 | 0.14 | 0.14 | 0.14 | 7,121,121 | |
| 04/01/2024 | 0.15 | 0.15 | 0.14 | 0.14 | 4,946,071 | |
| 03/29/2024 | 0.14 | 0.15 | 0.14 | 0.15 | 5,598,514 | |
| 03/28/2024 | 0.14 | 0.15 | 0.14 | 0.15 | 5,401,804 | |
| 03/27/2024 | 0.14 | 0.15 | 0.14 | 0.14 | 5,490,990 | |
| 03/26/2024 | 0.14 | 0.14 | 0.14 | 0.14 | 4,469,861 | |
| 03/25/2024 | 0.14 | 0.14 | 0.13 | 0.13 | 4,517,268 | |
| 03/22/2024 | 0.14 | 0.14 | 0.13 | 0.14 | 1,766,802 | |
| 03/21/2024 | 0.13 | 0.14 | 0.13 | 0.14 | 4,124,271 | |
| 03/20/2024 | 0.13 | 0.14 | 0.13 | 0.13 | 3,534,235 | |
| 03/19/2024 | 0.13 | 0.13 | 0.13 | 0.13 | 3,740,693 | |
| 03/18/2024 | 0.13 | 0.13 | 0.13 | 0.13 | 3,352,160 | |
| 03/15/2024 | 0.13 | 0.13 | 0.13 | 0.13 | 4,165,755 | |
| 03/14/2024 | 0.13 | 0.14 | 0.13 | 0.13 | 5,883,954 | |
| 03/13/2024 | 0.13 | 0.14 | 0.13 | 0.14 | 3,078,000 | |
| 03/12/2024 | 0.14 | 0.14 | 0.13 | 0.13 | 3,680,572 | |
| 03/11/2024 | 0.14 | 0.14 | 0.14 | 0.14 | 4,183,553 | |
| 03/08/2024 | 0.14 | 0.14 | 0.14 | 0.14 | 4,412,300 | |
| 03/07/2024 | 0.13 | 0.14 | 0.13 | 0.14 | 4,848,536 | |
| 03/06/2024 | 0.14 | 0.14 | 0.13 | 0.13 | 3,483,543 | |
| 03/05/2024 | 0.14 | 0.14 | 0.13 | 0.14 | 3,574,940 | |
| 03/04/2024 | 0.16 | 0.16 | 0.14 | 0.14 | 7,779,638 | |
| 03/01/2024 | 0.14 | 0.16 | 0.14 | 0.16 | 11,877,562 | |
| 02/29/2024 | 0.13 | 0.15 | 0.13 | 0.14 | 9,180,940 | |
| 02/28/2024 | 0.12 | 0.14 | 0.12 | 0.14 | 16,035,316 | |
| 02/27/2024 | 0.12 | 0.12 | 0.12 | 0.12 | 5,033,202 | |
| 02/26/2024 | 0.13 | 0.13 | 0.12 | 0.12 | 3,041,426 | |
| 02/23/2024 | 0.13 | 0.13 | 0.12 | 0.13 | 3,422,600 | |
| 02/22/2024 | 0.13 | 0.13 | 0.12 | 0.12 | 6,319,619 | |
| 02/21/2024 | 0.13 | 0.13 | 0.13 | 0.13 | 4,565,112 | |
| 02/20/2024 | 0.13 | 0.14 | 0.13 | 0.13 | 6,801,700 | |
| 02/16/2024 | 0.14 | 0.14 | 0.12 | 0.12 | 10,957,109 | |
| 02/15/2024 | 0.13 | 0.14 | 0.13 | 0.14 | 2,510,433 | |
| 02/14/2024 | 0.13 | 0.14 | 0.13 | 0.13 | 4,241,466 | |
| 02/13/2024 | 0.14 | 0.14 | 0.13 | 0.13 | 3,066,857 | |
| 02/12/2024 | 0.13 | 0.14 | 0.13 | 0.14 | 6,700,733 | |
| 02/09/2024 | 0.12 | 0.13 | 0.12 | 0.13 | 4,083,740 | |
| 02/08/2024 | 0.13 | 0.13 | 0.13 | 0.13 | 3,408,424 | |
| 02/07/2024 | 0.13 | 0.13 | 0.13 | 0.13 | 2,685,828 | |
| 02/06/2024 | 0.12 | 0.13 | 0.12 | 0.13 | 3,565,893 | |
| 02/05/2024 | 0.13 | 0.13 | 0.12 | 0.13 | 6,886,806 | |
| 02/02/2024 | 0.13 | 0.13 | 0.13 | 0.13 | 3,709,889 | |
| 02/01/2024 | 0.13 | 0.14 | 0.13 | 0.13 | 2,874,436 | |
| 01/31/2024 | 0.14 | 0.14 | 0.13 | 0.13 | 3,413,874 | |
| 01/30/2024 | 0.14 | 0.14 | 0.13 | 0.14 | 5,776,300 | |
| 01/29/2024 | 0.13 | 0.14 | 0.13 | 0.13 | 3,564,024 |
About Zomedica Pharmaceuticals Stock history
Zomedica Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Zomedica is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Zomedica Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Zomedica Pharmaceuticals stock prices may prove useful in developing a viable investing in Zomedica Pharmaceuticals
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 979.9 M | 1 B | |
| Net Loss | -15.3 M | -16.1 M |
Zomedica Pharmaceuticals Quarterly Net Working Capital |
|
Zomedica Pharmaceuticals Stock Technical Analysis
Zomedica Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Piotroski F Score Now
Piotroski F ScoreGet Piotroski F Score based on the binary analysis strategy of nine different fundamentals |
| All Next | Launch Module |
Zomedica Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Zomedica Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Zomedica Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Zomedica to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.026 | |||
| Jensen Alpha | 0.042 | |||
| Total Risk Alpha | (0.58) | |||
| Sortino Ratio | 0.0077 | |||
| Treynor Ratio | 0.1107 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Zomedica Pharmaceuticals Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Complementary Tools for Zomedica Stock analysis
When running Zomedica Pharmaceuticals' price analysis, check to measure Zomedica Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Zomedica Pharmaceuticals is operating at the current time. Most of Zomedica Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Zomedica Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Zomedica Pharmaceuticals' price. Additionally, you may evaluate how the addition of Zomedica Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences |
Is Zomedica Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Zomedica Pharmaceuticals. If investors know Zomedica will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Zomedica Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.03) | Revenue Per Share 0.026 | Quarterly Revenue Growth 0.192 | Return On Assets (0.07) | Return On Equity (0.14) |
The market value of Zomedica Pharmaceuticals is measured differently than its book value, which is the value of Zomedica that is recorded on the company's balance sheet. Investors also form their own opinion of Zomedica Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Zomedica Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Zomedica Pharmaceuticals' market value can be influenced by many factors that don't directly affect Zomedica Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Zomedica Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Zomedica Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Zomedica Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.